ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.017498903403062 0.25438734
NSC 748715 Null 0.017498903403062 0.34865909
NSC 282159 EN 589 0.0178844438004194 0.085828018
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0178844438004194 0.49990249
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0178844438004194 0.49130102
NSC 364830 Camptothecin Derivative 0.0178844438004194 0.51618951
NSC 610457 Camptothecin Derivative 0.0178844438004194 0.5059983
NSC 644582 Hydrazinecarboximidamide, 2-[(1H-indol-3-yl)methylene]- N-phenyl-, nitrate 0.0178844438004194 -0.25669301
NSC 651774 Null 0.0178844438004194 0.33316468
NSC 676343 Null 0.0178844438004194 0.3249211
Total:64  Current:29    [First] [Prev] [Next] [Last]